GH Research PLC Ordinary Shares

GHRSNASDAQUSD
27.75 USD
0.14 (0.51%)🟢PRE MARKET (AS OF 04:01 AM EDT)
🟢Market: OPEN

GH Research PLC Ordinary Shares (GHRS) trades at $27.75 per share. Technical indicators currently signal "Sell". This is driven by a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Sep 15, 2026.

Open?$27.66
High?$27.75
Low?$27.66
Prev. Close?$27.89
Volume?N/A
Avg. Volume?N/A
Bid / Ask
Bid?$23.69 × 100
Ask?$32.92 × 100
Spread?$9.23
Midpoint?$28.31
Valuation & Ratios
Market Cap?1.9B
Shares Out?68.6M
Float?36.4M
Float %?53.1%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Employees
73
Market Cap
1.9B
Industry
N/A
Listed
2021-06-25
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-1/3)
Medium-Term (Wave)? Bearish(-1/3)
Short-Term (Ripple)? Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?8.46%Elevated
Short Interest?3.1M
Days to Cover?18.5
Free Float36.4M
Avg Daily Volume166.6K
Settlement Date2026-08-31